Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06998 GENOR-B > Detailed Quotes

06998 GENOR-B

1.730
-0.020-1.14%
Trading Session 09/27 13:25 CCT
High
1.810
Open
1.720
Turnover
211.68K
Low
1.710
Pre Close
1.750
Volume
120.50K
Market Cap
872.17M
P/E(TTM)
Loss
52wk High
14.180
Shares
504.14M
P/E(Static)
Loss
52wk Low
1.570
Float Cap
872.17M
Bid/Ask %
62.85%
Historical High
32.200
Shs Float
504.14M
Volume Ratio
0.23
Historical Low
1.570
Dividend TTM
--
Div Yield TTM
--
P/B
0.35
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.02%
Amplitude
5.71%
Avg Price
1.756
Lot Size
500
Float Cap
872.17M
Bid/Ask %
62.85%
Historical High
32.200
Shs Float
504.14M
Volume Ratio
0.23
Historical Low
1.570
Dividend TTM
--
P/B
0.35
Dividend LFY
--
Turnover Ratio
0.02%
Amplitude
5.71%
Avg Price
1.756
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Jiahe Biopharmaceutical (Cayman) Holdings Co., Ltd. is a Chinese company mainly engaged in the research and development of biopharmaceutical products. The company specializes in the development and commercialization of oncology and autoimmune diseases. The company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The company mainly does business in the Chinese market.
CEO: Feng Guo
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...